| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |